Synthesis of 2-Fluoro-11-hydroxy-N-propylnoraporphine:  A Potential Dopamine D2 Agonist

Ao Zhang, Csaba Csutoras, Rushi Zong, and John L Neumeyer*
Medicinal Chemistry Laboratory, Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478
Org. Lett., 2005, 7 (15), pp 3239–3242
DOI: 10.1021/ol051010d
Publication Date (Web): June 18, 2005
Copyright © 2005 American Chemical Society

 Current Address: Department of Chemistry, Eszterházy Károly University, 4 Leányka Street, Eger, Hungary, H-3300.

,
*

In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

, neumeyer@mclean.harvard.edu

Abstract

Abstract Image

2-Fluoro-11-hydroxy-N-propylnoraporphine 4 (2-F-11-OH-NPa) was synthesized from thebaine in 13 steps with an overall yield of 1.35%. The key steps included the Pd-catalyzed 3-dehydroxylation of 14-hydroxymorphine, SN2 substitution of Ts- by F-, and CH3SO2OH-promoted rearrangement of the substituted morphinandiene. The dopamine binding affinity of this compound was also investigated on rat brain membranes, and as expected, this compound displayed high affinity and selectivity at the D2 receptor.

Tools

History

  • Published In Issue July 21, 2005
  • Received May 3, 2005

Recommend & Share

Related Content

Other ACS content by these authors: